EMERGE Biobank
Start date:June 2013 End date:
December 2015 Co-ordinated by:
EMERGE
The Emergency Medicine Annotated Bioresource Consortium (EM-ABC): A pilot and feasability programme
Aim
To develop the infrastructure and pilot a prospective, consecutive, emergency, bioresource that will subsequently be developed for all emergency presentations
Trial Design
A pilot and feasibility programme to establish a bioresource to provide consecutive emergency samples, thus enabling investigation of the development of the acute disease/influence of disease modifiers e.g. treatment and resuscitation.
Chief Investigator
Dr Matt Reed
Local PI
Dr Matt Reed
Research Team
Paul Leonard, Sandra McGillivray, TRAK development team
Dawn Lyster, John Connolly, RIE laboratories
Chief Investigator
Dr Matt Reed
Director of EMERGE, Consultant, NRS Career Research Fellow & Honorary Reader in Emergency Medicine
Local PI
Dr Matt Reed
Director of EMERGE, Consultant, NRS Career Research Fellow & Honorary Reader in Emergency Medicine
Research Team
Rachel O'Brien
Lead Research Nurse
More EMERGE Trials
To determine the association between high-sensitivity cardiac troponin concentration and obstructive coronary artery disease in patients presenting to the Emergency Department with suspected acute coronary syndrome and cardiac troponin concentration within the normal reference range using CTCA.
PRECISE-CTCA Trial
To determine the association between high-sensitivity cardiac troponin concentration and obstructive coronary artery disease in patients presenting to the Emergency Department with suspected acute coronary syndrome and cardiac troponin concentration within the normal reference range using CTCA.
Identification and characterization of the clinical toxicology of novel psychoactive substances (NPS) by laboratory analysis of biological samples from recreational drug users.
IONA Study
Identification of Novel Psychoactive Substances (IONA)